Tibet Rhodiola Pharmaceutical Holding Co (600211) — Free Cash Flow Generation Index
Tibet Rhodiola Pharmaceutical Holding Co (600211) has a Free Cash Flow Generation Index of 0.98x as of December 2025. Free cash flow of CN¥292.88 Million represents 1% of operating cash flow (CN¥297.86 Million). Read Tibet Rhodiola Pharmaceutical Holding Co (600211) financial obligations for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Tibet Rhodiola Pharmaceutical Holding Co Free Cash Flow Generation Index (1999–2025)
Historical FCF Generation Index trend for Tibet Rhodiola Pharmaceutical Holding Co across 25 annual periods. Explore 600211 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Tibet Rhodiola Pharmaceutical Holding Co (1999–2025)
Year-by-year Free Cash Flow Generation Index for Tibet Rhodiola Pharmaceutical Holding Co. For the full company profile including market capitalisation, see Tibet Rhodiola Pharmaceutical Holding Co (600211) total market value.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.98x | CN¥1.01 Billion | CN¥1.03 Billion | CN¥15.96 Million | ▲ +2.3% |
| 2024 | 0.96x | CN¥957.19 Million | CN¥994.79 Million | CN¥37.60 Million | ▼ 0.0% |
| 2023 | 0.96x | CN¥1.04 Billion | CN¥1.08 Billion | CN¥21.69 Million | ▲ +9.6% |
| 2022 | 0.88x | CN¥735.41 Million | CN¥837.38 Million | CN¥101.96 Million | ▲ +645.2% |
| 2021 | -0.16x | CN¥-59.05 Million | CN¥366.53 Million | CN¥425.58 Million | ▼ -133.3% |
| 2020 | 0.48x | CN¥206.88 Million | CN¥428.17 Million | CN¥221.29 Million | ▼ -46.3% |
| 2019 | 0.90x | CN¥440.60 Million | CN¥489.59 Million | CN¥49.00 Million | ▼ -2.1% |
| 2018 | 0.92x | CN¥265.85 Million | CN¥289.22 Million | CN¥23.37 Million | ▲ +116.3% |
| 2017 | -5.65x | CN¥-516.52 Million | CN¥91.46 Million | CN¥607.98 Million | ▼ -687.4% |
| 2016 | 0.96x | CN¥240.56 Million | CN¥250.21 Million | CN¥9.64 Million | ▲ +4.5% |
| 2015 | 0.92x | CN¥123.27 Million | CN¥133.93 Million | CN¥10.66 Million | ▲ +4.8% |
| 2013 | 0.88x | CN¥245.10 Million | CN¥279.22 Million | CN¥34.12 Million | ▼ -4.7% |
| 2012 | 0.92x | CN¥51.78 Million | CN¥56.20 Million | CN¥4.42 Million | ▲ +13.9% |
| 2011 | 0.81x | CN¥9.78 Million | CN¥12.09 Million | CN¥2.31 Million | ▲ +326.8% |
| 2010 | -0.36x | CN¥-677.71K | CN¥1.90 Million | CN¥2.58 Million | ▼ -145.0% |
| 2009 | 0.79x | CN¥14.18 Million | CN¥17.88 Million | CN¥3.70 Million | ▲ +2.2% |
| 2008 | 0.78x | CN¥16.66 Million | CN¥21.46 Million | CN¥4.80 Million | ▲ +47.2% |
| 2006 | 0.53x | CN¥17.73 Million | CN¥33.63 Million | CN¥15.90 Million | ▼ -15.8% |
| 2005 | 0.63x | CN¥11.85 Million | CN¥18.92 Million | CN¥7.07 Million | ▲ +78.2% |
| 2004 | 0.35x | CN¥9.46 Million | CN¥26.90 Million | CN¥17.45 Million | ▼ -31.8% |
| 2003 | 0.52x | CN¥24.33 Million | CN¥47.20 Million | CN¥22.88 Million | ▲ +124.4% |
| 2002 | -2.11x | CN¥-69.29 Million | CN¥32.85 Million | CN¥102.14 Million | ▲ +49.2% |
| 2001 | -4.15x | CN¥-64.25 Million | CN¥15.47 Million | CN¥79.72 Million | ▲ +12.8% |
| 2000 | -4.76x | CN¥-97.89 Million | CN¥20.55 Million | CN¥118.45 Million | ▲ +82.5% |
| 1999 | -27.15x | CN¥-61.00 Million | CN¥2.25 Million | CN¥63.25 Million | — |